21-Nov-2024 5:00 AM CST - Business Wire Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024. Quantum-Sis Management team announced Platinum Pro, the Companys evolution of Platinum, as well as Proteus, the Companys new cutting-edge proteomics platform of the future, that is now under development. We are very excited t
12-Nov-2024 6:30 AM CST - Business Wire Quantum-Si Reports Third Quarter 2024 Financial Results Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio has integrated Platinum Next-Generation Sequencing into their platform for developing novel gene therapies with improved targeting capabilities Announced appoi
5-Nov-2024 8:00 AM CST - Business Wire Quantum-Si to Participate in Upcoming Investment Conferences Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced that it will be participating in two upcoming investment conferences. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT. On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside
31-Oct-2024 2:35 PM CST - Business Wire Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024. Quantum-Sis management team will provide updates on the Companys evolving technology roadmap, emerging applications for protein sequencing and the expanding commercial opportunities that these innovations create. A live question and ans
31-Oct-2024 5:00 AM CST - Business Wire Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024. Quantum-Sis management team will provide updates on the Companys evolving technology roadmap, emerging applications for protein sequencing and the expanding commercial opportunities that these innovations create. A live question and ans
21-Nov-2024 5:00 AM CST - Business Wire Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024. Quantum-Sis Management team announced Platinum Pro, the Companys evolution of Platinum, as well as Proteus, the Companys new cutting-edge proteomics platform of the future, that is now under development. We are very excited t
12-Nov-2024 6:30 AM CST - Business Wire Quantum-Si Reports Third Quarter 2024 Financial Results Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio has integrated Platinum Next-Generation Sequencing into their platform for developing novel gene therapies with improved targeting capabilities Announced appoi
5-Nov-2024 8:00 AM CST - Business Wire Quantum-Si to Participate in Upcoming Investment Conferences Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced that it will be participating in two upcoming investment conferences. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT. On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside
31-Oct-2024 2:35 PM CST - Business Wire Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024. Quantum-Sis management team will provide updates on the Companys evolving technology roadmap, emerging applications for protein sequencing and the expanding commercial opportunities that these innovations create. A live question and ans
31-Oct-2024 5:00 AM CST - Business Wire Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 Quantum-Si Incorporated (Nasdaq: QSI) (Quantum-Si, QSI or the Company), The Protein Sequencing Company, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024. Quantum-Sis management team will provide updates on the Companys evolving technology roadmap, emerging applications for protein sequencing and the expanding commercial opportunities that these innovations create. A live question and ans
